行情

AMAG

AMAG

Amag制药
NASDAQ

实时行情|Nasdaq Last Sale

5.94
-0.62
-9.45%
盘后: 5.94 0 0.00% 16:56 03/27 EDT
开盘
6.42
昨收
6.56
最高
6.44
最低
5.92
成交量
47.12万
成交额
--
52周最高
13.53
52周最低
4.410
市值
2.04亿
市盈率(TTM)
-0.4335
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AMAG价格均价为9.44,最高价位12.00,最低价为6.00。

EPS

AMAG 新闻

更多
  • AMAG Pharmaceuticals (AMAG) Moves to Buy: Rationale Behind the Upgrade
  • Zacks · 4天前
  • AMAG Pharmaceuticals (AMAG) Presents At Barclays Global Healthcare Conference - Slideshow
  • Seeking Alpha - Article · 03/13 18:31
  • Edited Transcript of AMAG earnings conference call or presentation 4-Mar-20 1:00pm GMT
  • Thomson Reuters StreetEvents · 03/13 03:33
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37

所属板块

制药
-0.41%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

AMAG 简况

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.
展开

微牛提供AMAG Pharmaceuticals, Inc.(NASDAQ-AMAG)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AMAG股票新闻,以帮助您做出投资决策。